0001415889-24-024991.txt : 20241010 0001415889-24-024991.hdr.sgml : 20241010 20241010203822 ACCESSION NUMBER: 0001415889-24-024991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241008 FILED AS OF DATE: 20241010 DATE AS OF CHANGE: 20241010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kintz Samuel CENTRAL INDEX KEY: 0001967168 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39247 FILM NUMBER: 241366153 MAIL ADDRESS: STREET 1: ENLIVEN THERAPEUTICS INC STREET 2: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enliven Therapeutics, Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811523849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-647-8519 MAIL ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: IMARA Inc. DATE OF NAME CHANGE: 20160419 4 1 form4-10112024_121018.xml X0508 4 2024-10-08 0001672619 Enliven Therapeutics, Inc. ELVN 0001967168 Kintz Samuel C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD BOULDER CO 80301 true true false false PRESIDENT AND CEO 1 Common Stock 2024-10-08 4 S 0 13167 27.9546 D 1020626 I See footnote Common Stock 2024-10-08 4 S 0 100 28.51 D 1020526 I See footnote Common Stock 2024-10-09 4 S 0 13880 28.0746 D 1006646 I See footnote Common Stock 2024-10-09 4 S 0 2830 28.5264 D 1003816 I See footnote The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. This transaction was executed in multiple trades at prices ranging from $27.50 to $28.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee. This transaction was executed in multiple trades at prices ranging from $27.50 to $28.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $28.51to $28.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. /s/ Ben Hohl, by power of attorney 2024-10-10